|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Kappa/Lambda Light Chain Free Serum
Test CodeKAPPA/LAMBDA LIGHT-CHAIN FREE SERUM
Preferred Specimen
Gold Top Tube
Minimum Volume
2 mL
Transport Temperature
Refrigerate
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Reject if 3+ or 4+ lipemia/icterus/hemolysis
Methodology
Optilite/Colorimetric
Setup Schedule
M-F
Report Available
TAT 2 - 5 days
Reference Range
| TEST | RANGE |
| Free Kappa | 3.30-19.40 mg/L |
| Free Lambda | 5.71-26.30 mg/L |
| Ratio | 0.26 to 1.65 |
Clinical Significance
Elevated serum levels of monoclonal free light chains with abnormal free kappa/free lambda ratios is associated with malignant plasma cell disorders including multiple myeloma, nonsecretory multiple myeloma, light chain disease, and primary amyloidosis. This assay may also be useful in monitoring the treatment of patients previously diagnosed with multiple myeloma.
High or low ratios are suggestive of monoclonal gammopathies.
High or low ratios are suggestive of monoclonal gammopathies.
Performing Laboratory
Test performed in the West Roxbury Immunology Lab
Contact: Cassandra Mota, 857-203-5941
Last Updated: June 25, 2026

